Found 11 matching trials
Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants PHASE2 Elvucitabine, a novel nucleoside analog, is being studied as a treatment fo...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load. PHASE2 To determine safety and efficacy of ACH-126,443 on the treatment of adults ...
Show More Location
Body Positive, Inc.
Learn More & Join Trial
Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A PHASE2 To assess the safety of 48 weeks of treatment with 10 milligrams (mg) of el...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Safety Study of Elvucitabine in HIV-1 Subjects PHASE2 The purpose of this 28 day study is to assess the viral kinetics and safety...
Show More Location
Thomas Jefferson University
Learn More & Join Trial
Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation PHASE1 Human immunodeficiency virus (HIV)-1 infected participants receiving long-t...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection PHASE2 The purpose of this study was to determine the safety and anti-hepatitis B ...
Show More Location
Clinical Trial Site
Learn More & Join Trial
A Study of DPC 817 in HIV-Infected Males PHASE1 The purpose of this study is to evaluate DPC 817. The safety, dosages, and ...
Show More Location
University of North Carolina Hospitals
Learn More & Join Trial
An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment PHASE2 Extension study for participants currently participating in Protocols ACH44...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection. NA The purpose of this study is to determine the safety and antiviral HBV acti...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B PHASE2 The purpose of this study was to determine the safety and antiviral hepatit...
Show More Location
Clinical Trial Site
Learn More & Join Trial